Otolaryngologic surgery in children with von Willebrand disease

Victor Jiménez-Yuste1, María P Prim, Juan I De Diego

  • 1C/ Arzobispo Morcillo No. 12, 1 C 28029, Madrid, Spain.

Insights

Otolaryngologic surgery in children with von Willebrand disease (vWD) is effective, but desmopressin use requires caution due to potential seizures. Careful monitoring is essential for managing bleeding risks and adverse effects.

Area of Science:

  • Pediatric Otolaryngology
  • Hematology
  • Pharmacology

Background:

  • Von Willebrand disease (vWD) presents unique challenges in pediatric surgical patients.
  • Otolaryngologic procedures are common in children and may be complicated by bleeding disorders.

Purpose of the Study:

  • To evaluate the safety and efficacy of otolaryngologic surgery in children diagnosed with von Willebrand disease (vWD).
  • To assess postoperative bleeding, hyponatremia, seizures, and urine output as key outcome measures.

Main Methods:

  • A prospective, controlled study involving 41 pediatric patients with vWD undergoing surgery.
  • Treatment protocols included desmopressin acetate and tranexamic acid, or factor VIII concentrate for specific cases.
  • Data collection focused on immediate/delayed bleeding, hyponatremia, seizures, and urine output.

Main Results:

  • Two patients (5%) experienced immediate postoperative hemorrhage following adenotonsillectomy.
  • No delayed postoperative bleeding was observed.
  • Severe hyponatremia occurred in two patients, with one exhibiting clinical symptoms.

Conclusions:

  • The implemented management strategy for children with vWD undergoing otolaryngologic surgery proved efficacious.
  • One patient experienced a seizure, an adverse effect linked to desmopressin, highlighting the need for careful administration and monitoring.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
324
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
975
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
570